EIT Health launches seven new members to its community

EIT Health is delighted to announce that seven new members have joined our portfolio of over one hundred of the most influential actors in healthcare.  

Representing a broad range of specialisms, each organisation enhances our shared commitment to driving innovation across Europe. As our network continues to grow, we remain focused on collaborative excellence and the advancement of sustainable, patient-centered health solutions. The contributions of our members are instrumental in progressing our mission to transform healthcare in Europe and beyond—a collective achievement that reflects our dedication to meaningful impact.

“It is with great enthusiasm that I welcome these seven new members to our community. Their innovative spirit and commitment to transforming healthcare will enhance our collective ability to tackle the challenges of today, as well as those yet to come. – Jean‐Marc Bourez, EIT Health CEO.

On behalf of our Supervisory Board and everyone at EIT Health, we extend a warm welcome to:

• Britenet Med (Poland), equipping companies with knowledge, technology, and tools through consulting and IT outsourcing;
• E-Seniors (France), a nonprofit organisation that combats e-exclusion, and promotes active living, by providing ICT training and active ageing products and programmes for senior citizens;
• GSK (Spain), advancing disease prevention and digital healthcare through innovative research and biopharmaceutical development;
• The Health Proof Helsinki (Finland), Finland’s leading healthtech testing ecosystem, offering integrated support for companies from preclinical trials to clinical research;

• OptiMedis (Germany) pioneers in sustainable, patient-centred health system models through regional partnerships and data-driven healthcare management;

• Takeda France and Takeda Serbia, two more regions from the Takeda network join us, driving biopharmaceutical innovation and patient-centred healthcare across Europe, with a strong focus on research, collaboration, and unmet medical needs.

About the members
The support of our members is essential to driving forward our mission to transform healthcare across Europe and beyond. Read below to find out more about each of our new members or visit our website to view the full list.

Britenet Med (Poland)

Britenet Med, based in Poland, is behind the innovative solution MoodMon – an AI-driven monitoring tool designed to enhance the treatment of patients with chronic affective disorders such as bipolar disorder and recurrent depression. MoodMon provides continuous, objective tracking of mental health symptoms, supporting patients, caregivers, and clinicians in monitoring mood changes and adjusting treatment accordingly.

“We are pleased to deepen our collaboration by joining EIT Health as a member. We are confident that this will enable us to connect with additional exceptional partners across Europe, fostering the exchange of knowledge and expertise to enhance the treatment of mental illness on a global scale,” Małgorzata Sochacka, Originator, MoodMon and Product Manager, Britenet Med.

E-Seniors (France)

Founded in 2005 by General Manager Monique Epstein, E-Seniors is a nonprofit organisation which aims to fight e-exclusion by offering ICT training to senior citizens. Its main objectives are to bridge the digital gap between generations, to foster senior citizen’s social participation, and to propose activities that encourage senior citizens to spend their free time actively. Aware of the challenges that both healthy and dependent senior citizens face, the organisation is involved in the development of new products and services which aim to boost independent living and maintain physical and mental health. E-Seniors also boasts a wealth of experience in the management of projects related to ICT tools and healthy ageing financed by European programmes, such as Horizon 2020 and Erasmus+. E-Seniors is upgrading to full membership after having been a network member of EIT Health France since the beginning.

“Although it is only a small association that represents the end user, E-Seniors is aware of the importance of its role in the research and development process of new products and systems in all phases of project development. We strongly believe in the importance of the existing synergy between partners from different fields of activity, including academics, industrialists and businessmen: and this is the reason for its membership with EIT Health!,” Monique Epstein, General Manager, E-Seniors.

GSK (Spain)

GSK Spain is the Spanish arm of the global biopharmaceutical company GSK, dedicated to uniting science, technology and talent to get ahead of disease. With a strong presence in research, vaccines and primary care medicines, GSK Spain plays a key role in advancing disease prevention, accelerating the development of innovative therapies, and promoting digital transformation in healthcare.

GSK’s focus for the EIT Health alliance is to drive sustainable healthcare system transformation, enhance digital skills among healthcare professionals, and foster collaboration and knowledge exchange across the broader health ecosystem.

Jorge Pou, Innovation & Commercial Acceleration Director at GSK Spain, emphasises, “The agreement with EIT Health allows us to collaborate in a cutting-edge innovation environment in Europe, promoting projects that address unmet needs in healthcare through digitalisation and disruptive science. Together, we will work towards a more resilient and sustainable healthcare system”.

OptiMedis (Germany)

Founded in 2003, OptiMedis is an innovative health management, analytics, and research company based in Hamburg. Dedicated to expanding social benefit, its focus lies on developing progressive models for patient-orientated, sustainable health that can be implemented at both regional and national levels. Collaboration with doctors, hospitals, healthcare professionals, health insurance companies, local authorities, and digital solution providers is at the heart of its work. OptiMedis builds regional partnerships, negotiates contracts, establishes structures such as intersectoral health and medical centres, manages operations, and implements digital solutions.

“Joining EIT Health Germany-Switzerland is an exciting opportunity for OptiMedis. We are eager to collaborate with other forward-thinking partners within the EIT Health network to drive systemic innovation in healthcare and scale our impact across Europe.”
– Dr h.c. Helmut Hildebrandt, CEO OptiMedis.

The Health Proof Helsinki (Finland)

The Health Proof Helsinki ecosystem was established upon recognizing that the combined expertise of Finland’s three most significant RDI environments could best provide testing and research services for companies, projects, initiatives, and researchers in the field. The Health Proof Helsinki ecosystem offers smooth access for healthtech and medtech companies to expertise, facilities, and equipment at various stages of product and service development – from preclinical to clinical testing and research – through a unified customer journey. As such, Health Proof Helsinki is Finland’s leading consortium in the sector, offering services that cover the entire service chain.

 “We are excited to join EIT Health as a member since it aligns perfectly with our ambition to collaborate across sectors—bringing together stakeholders from business, academia, healthcare, and civil society—to drive innovation in patient care, stimulate investment, create high-quality jobs, and promote sustainable growth. Being part of the EIT Health network offers us valuable access to the latest European developments, thought leadership, and strategic opportunities to co-create with leading international organizations. We particularly value EIT Health’s matchmaking and one-to-one engagement, as we see these as essential for building trusted relationships, forming impactful consortia, and launching joint innovation projects with real societal value.” – Eija Raussi-Lehto.

Takeda France and Serbia 

The Takeda Pharmaceutical Company Limited, headquartered in Japan, is a globally recognised leader in biopharmaceuticals with over 240 years of history. Its mission focuses on improving patient health worldwide through transformative therapies, driven by innovative research and development.  Takeda advances R&D in five key areas: rare diseases, oncology, gastroenterology, neuroscience, and plasma-derived therapies. It also contributes to vaccine development, including a recent dengue vaccine approval. The company is committed to a culture of integrity, fairness, and dedication to inclusion, fostering a dynamic and innovative working atmosphere. With operations in nearly 80 countries, Takeda aims to transform science into innovative medicines that improve lives globally.

Both Takeda France and Serbia are joining Takeda Scandinavia as part of the EIT Health community.

“Joining EIT Health is a natural step for us, as we believe collaboration is key to transforming healthcare. At Takeda Eastern Europe, we’re driven by a commitment to support the development of innovative, patient-focused initiatives – especially in areas identified as having significant unmet needs. Through this partnership, we’re looking to connect with like-minded innovators and explore value-based projects that generate meaningful data, contribute to better healthcare delivery, and support more data-informed healthcare strategies. We see real potential in contributing to a stronger, more integrated innovation ecosystem in the region – one that puts patients first and accelerates impactful change.” – Milena Argirovic, Country Head Serbia, Albania, Macedonia, Kosovo and Montenegro at Takeda.

In Serbia, Takeda plays a key role in advancing healthcare through research, diversity, and collaboration with local communities, shaping a brighter future for all patients.

Join our community of innovators

If your organisation is interested in joining EIT Health and collaborating with the brightest minds in healthcare, learn more here.